MedTrace Logo

Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children

NCT01766310 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-12-11

Study results available
· View outcomes & findings →

Summary

The purpose of the present study was to determine whether folic acid supplementation could reduce plasma homocysteine in obese children and to determine the association between dietary folate, serum folate and homocysteine level through the randomized double blinded placebo controlled trial.

Conditions

Interventions

DRUG

Folic Acid

yellow tablet contained 5mg of folic acid, manufactured from the Government Pharmaceutical Organization, Ministry of Public Health, Thailand

DRUG

placebo

sugar tablet manufactured to mimic folic acid tablet

Sponsors & Collaborators

  • Chulalongkorn University

    collaborator OTHER

  • Queen Sirikit National Institute of Child Health

    lead OTHER_GOV

Principal Investigators

  • Orawan Iamopas, MD. · Queen Sirikit National Institute of Child Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
9 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01766310 on ClinicalTrials.gov